Abstract
ALUMNI AD Study Design: Evaluation of Subcutaneous Gantenerumab in Historically Underrepresented US Populations With Early Symptomatic Alzheimer’s Disease (S26.006)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have